James Flynn Net Worth & Insider Trades

James Flynn Homology Medicines, Inc

As of January 31, 2020

What is James Flynn's Net Worth?

The current estimated net worth of Homology Medicines, Inc's James Flynn is estimated to be about $982.18M . James Flynn owns about 2,321,199 units of Homology Medicines, Inc common stock. In the last 2 years at Homology Medicines, Inc, James Flynn has sold an estimated value of $29.32M worth.

What is James Flynn's Past Insider Trading?

James Flynn's largest purchase order was 5,227,035 units , worth over $20M on April 4, 2018. James Flynn's largest sale order was 639,506 units , worth over $10.04M on January 28, 2020. In total, James Flynn has made about 8 transactions over 2 years of their time at Homology Medicines, Inc. James Flynn usually trades in January, April and December, with the busiest year in 2019. The most recent transaction was a sale order of 518,827 units , worth over $8.02M on January 31, 2020.

James Flynn, DEERFIELD MANAGEMENT COMPANY LP SERIES C, Deerfield Mgmt LP, DEERFIELD PARTNERS LP, Deerfield Private Design Fund III LP, Deerfield Mgmt III LP, Deerfield Healthcare Innovations Fund LP, Deerfield Mgmt HIF LP

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is James Flynn's' Mailing Address?

  • Mailing address is 780 Third Avenue 37th Floor New York NY 10017 NY

Homology Medicines, Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Arthur O. Tzianabos, Ph.D. 2020 $563,200 - - $309,760 $13,000 $885,960
Arthur O. Tzianabos, Ph.D. 2019 $537,600 - $4,217,097 $295,680 $12,500 $5,062,877
Albert Seymour, Ph.D. 2020 $426,800 - - $170,720 $10,057 $607,577
Albert Seymour, Ph.D. 2019 $405,600 - $1,295,756 $162,240 $13,231 $1,876,827
W. Bradford Smith 2020 $406,700 - - $162,680 $13,000 $582,380
W. Bradford Smith 2019 $384,200 - $1,307,536 $153,680 $14,880 $1,860,296
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1661998/000156459021021931/fixx-def14a_20210617.htm

What are Homology Medicines, Inc's Past Insider Trades?

Homology Medicines, Inc's most recent insider trade came on January 12, 2022 by W. Bradford Smith who sold 2,182 units worth $8.25K . In the last 4 years, insiders at Homology Medicines, Inc have sold an estimated value of $109.51M and bought an estimated value of $60.18M worth of shares. Insider trading is most common in June, with the busiest year in 2019. The most active traders at the company are Albert Seymour, See Remarks,  Timothy P Kelly, Chief Operating Officer,  and Arthur Tzianabos, President & CEO .

Homology Medicines, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1